Gene Query: TIAM1

Dataset Description Geneva Score
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 71.89
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 71.89
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 67.77
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 67.77
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 40.31
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 39.09
RNA-seq of human aneuploid cell lines with Trisomy 21 38.92
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 37.57
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 34.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 32.13
FOXP1 orchestration of ASD-relevant signaling pathways. 31.87
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 30.22
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 29.85
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 29.6
Transcriptomic and gene ontology profiling of the human corneal cell types 28.25
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 27.62
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 27.07
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 26.45
NR2F2 study 25.49
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 25.49
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 25.03
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 24.37
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 24.35
RNA-Seq from early time points in the kidney differentiation protocol 24.31
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 24.12
RNA sequencing analysis of human embryonic stem cells and axial progenitors 24.06
mRNA expression profile of Lymphocytes by high-throuput sequencing 23.57
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 23.18
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 23.18
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 21.38
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 21.35
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 21.06
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 21.01
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 20.95
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 20.83
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 20.55
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 20.48
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 20.24
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 20.24
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 19.99
Oncogenic MYC induces a dependency on the spliceosome in human cancer 19.58
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 19.55
Identification of long noncoding RNAs regulated by p53 19.34
ARID1A and ARID1B loss in HCT116 cells 19.31
FBXW7 modulates stress response by post-translational modification of HSF1 18.75
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 18.75
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 18.68
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 18.46
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 17.9
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 17.9
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 17.76
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 17.64
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 17.5
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 17.48
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 17.48
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 16.99
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 16.96
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 16.94
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 16.88
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 16.79
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 16.69
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 16.58
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 16.58
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 16.51
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 16.38
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 16.38
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 16.37
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 16.2
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 16.17
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 15.88
Gene expression profile of human iPSC-derived nephron progenitor cells 15.8
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 15.78
BASP1 modifies the Tamoxifen response 15.72
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 15.69
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 15.69
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 15.61
Gene Expression Profiling of WT and KDM3A Knocked out Cell 15.61
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 15.35
Genome wide expression change in LCC2 and MCF-7 cells 15.29
LncRNA-GAS5 negative regulation of YAP-target genes expression 15.18
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 15.16
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 15.13
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 15.13
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 15.06
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 14.98
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 14.92
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 14.78
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 14.53
RNA-seq analysis to identify the genes regulated by p53-SET interplay 14.33
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 14.16
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 14.16
CircRNAome diversity in human mature B-cells, T-cells and monocytes 14.09
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 13.86
Nucleoporin-mediated regulation of cell identity genes 13.76
Primary human trophoblast from term placenta 13.75
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 13.73
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 13.54
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 13.49
IMP3 regulated gene expression in breast cancer cells 13.43
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 13.36
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 13.28
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 13.28
Total RNA-seq in ALL-SIL upon JQ1 inhibition 13.03
Generation and functional characterization of MDSC-like cells 13.02
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 12.99
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 12.91
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 12.86
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 12.8
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 12.68
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 12.59
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 12.56
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 12.56
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 12.55
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 12.42
The role of FAM46C in myeloma cells 12.34
The role of FAM46C in myeloma cells [sequencing] 12.34
Transcriptome wide analysis of classically and alternatively activated macrophages 11.86
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 11.7
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.69
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 11.66
Conservative alteration of chromosomal expression pattern across human solid tumor types 11.59
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 11.44
Zika infected neural stem cells 11.44
Transcriptome analysis of Zika infected neural stem cells 11.44
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 11.41
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.37
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 11.34
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 11.33
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 11.33
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 11.3
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 11.27
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 11.12
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 11.08
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 11.08
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 11.08
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 11.08
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 11.0
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 10.91
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 10.83
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 10.83
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.68
Silencing SPIB in attached and floating state of H1703 lung cancer cells 10.65
Role of XRN2 ribonucleolytic activity in RNA metabolism 10.64
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 10.61
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 10.56
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 10.46
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 10.44
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 10.39
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 10.38
PTHrP overexpression in MCF7 cells 10.35
Accurate annotation of human protein-coding small open reading frames 10.17
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 10.16
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 10.07
Short and Long RNA sequencing of human mature erythrocytes 10.06
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 10.02
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 9.98
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 9.98
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 9.98
SNHG5 siRNA knock down in HCT116 cells 9.93
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.91
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 9.9
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 9.84
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 9.82
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 9.82
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.8
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 9.8
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 9.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 9.74
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 9.74
Lysine benzoylation is a novel histone mark [RNA-seq] 9.67
Lysine benzoylation is a novel histone mark 9.67
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.65
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 9.64
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 9.56
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 9.56
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 9.56
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 9.53
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.5
Depicting early human development and germ cell origin with porcine embryos 9.39
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 9.33
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 9.16
Identification of global regulators of T-helper cell lineage specification 9.06
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 9.06
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 9.03
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 9.01
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 8.96
Crizotinib v. DMSO in SW480 cells 8.92
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 8.91
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 8.83
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 8.83
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 8.78
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 8.71
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 8.7
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.69
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 8.61
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.52
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.52
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 8.5
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 8.5
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.46
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 8.46
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 8.4
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.37
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.37
RNA-seq of naive and primed ES cells (NHSM) 8.35
Stem and effector CD8 T-cells from human cancers 8.28
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 8.22
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 8.19
EP400 is required for Max and MCPyV mediated gene activation 8.16
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.16
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 8.11
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.11
RNAseq of T-ALL upon long non coding rna purturbation 8.07
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 8.07
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.06
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.04
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.01
Noncoding regions are the main source of targetable tumor-specific antigens 8.01
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 7.97
CDK12 mediated transcriptional regulation in U2OS cells 7.96
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 7.95
RNA-seq differential expression studies: more sequence, or more replication? 7.94
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.92
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.91
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 7.88
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 7.77
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 7.75
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 7.74
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.72
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.72
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 7.66
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.66
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.61
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.61
Maturation of human iNSCs 7.61
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 7.57
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 7.57
BI Human Reference Epigenome Mapping Project 7.55
LIN28A modulates splicing and gene expression programs in breast cancer cells 7.54
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 7.54
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 7.53
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 7.52
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 7.48
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 7.45
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 7.35
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 7.31
Effects of rFVIIIFc on human macrophages 7.22
Effect of Hotair overexpression in human breast cancer cell lines 7.2
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.19
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.19
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 7.13
Interaction between mitoNEET and NAF-1 in cancer cells 7.09
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 7.05
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 7.05
Lineage specific differentiation is influenced by state of human pluripotency 7.05
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 7.01
Dermal endothelial cells of type 2 diabetic patients 7.01
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.01
Anti-inflammatory effect of indoleacrylic acid (IA) 6.96
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.93
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 6.93
JunB control of keratinocyte-mediated inflammation [RNA-seq] 6.93
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 6.93
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 6.9
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.87
Patient-derived luminal breast cancer xenografts with progestins 6.87
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 6.86
Transciptomic profiling of human fetal lung samples 6.81
CHD1 regulates cell fate determination by activation of differentiation-induced genes 6.8
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.77
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 6.65
Global analysis of alternative splicing regulated by RBM10 6.65
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 6.62
Ribosomal protein RPL26 is the principal target of UFMylation 6.61
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 6.59
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.58
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 6.57
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 6.57
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 6.56
Macrophage Ad5f35 M2 Challenge 6.55
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.49
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 6.43
Intron retention induced by microsatellite expansions as a disease biomarker. 6.42
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 6.38
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 6.38
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 6.36
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 6.34
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 6.33
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 6.32
Mapping interactions for the TNIP2 hub protein 6.28
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 6.27
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 6.24
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 6.23
Proliferation-correlated expression 6.23
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 6.2
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 6.19
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 6.14
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 6.14
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 6.13
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.1
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 6.06
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 5.99
Transcriptome of Stabilin-1 siRNA transfected human monocytes 5.99
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 5.97
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 5.96
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 5.94
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.89
Hepatosplenic T cell lymphoma 5.89
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.84
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 5.84
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 5.8
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 5.8
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.72
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 5.67
iPSC-Derived Cholangiocytes 5.62
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 5.6
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 5.55
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.54
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.54
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 5.53
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 5.53
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 5.53
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.5
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 5.49
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 5.49
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.46
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.4
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.39
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 5.39
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 5.39
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.39
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.39
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 5.38
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 5.3
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 5.3
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.25
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.23
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.21
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 5.2
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.18
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.14
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.13
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.07
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.07
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.05
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.05
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 5.03
Transcriptomic profiling of human peripheral blood-derived mast cells 5.0
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.0
ARID1A and ARID1B loss in HCT116 and TOV21G cells 4.99
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 4.88
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.8
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.69
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.68
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 4.68
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.47
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.47
naive T cell heterogeneity after neonatal thymectomy 4.44
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 4.43
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 4.42
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 4.41
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 4.41
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.36
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.36
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 4.31
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.25
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.07
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.07
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.05
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 4.01
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 3.97
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.92
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.86
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.82
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.77
The MEF2B Regulatory Network 3.76
The MEF2B Regulatory Network - RNA-seq data 3.76
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 3.73
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 3.68
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 3.57
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.53
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 3.51
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.48
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.46
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 3.43
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.36
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.36
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.35
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.32
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 3.31
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 3.28
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.25
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 3.2
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.15
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.15
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.08
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.08
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.04
RNA sequencing analysis of selumetinib-resistant CRC cells lines 3.03
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.92
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.89
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.86
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 2.85
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.66
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.66
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.62
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.61
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.6
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.51
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.48
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.48
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.46
The age and genomic integrity of neurons after cortical stroke in humans 2.46
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.45
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.43
Dynamic 3D chromosomal landscapes in acute leukemia 2.38
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.38
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.26
Oncogenic roles of ARID5B in T-ALL 2.26
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.25
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.2
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.19
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.14
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.12
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.09
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 1.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 1.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 1.93
Leucegene: ALL sequencing 1.87
Aging-associated patterns in the expression of human endogenous retroviruses 1.85
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.77
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 1.76
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 1.76
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.76
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 1.73
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 1.65
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.64
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.63
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.63
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.54
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.52
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.48
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.42
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.42
Transcriptome analysis of peripheral blood monocytes 1.33
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.3
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 1.29
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.28
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.25
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.22
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.22
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.21
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.18
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.15
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.14
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.12
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.11
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 1.05
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.04
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.97
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.92
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.86
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.85
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.85
RNA-seq of SCLC PDX models treated with EP 0.82
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 0.8
Finding missing proteins from epigenetically manipulated human cells 0.75
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.71
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 0.69
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.63
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.62
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.62
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.6
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.6
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.58
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.58
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.58
BCL11B 0.54
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.5
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 0.49
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.49
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 0.47
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.45
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.43
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.4
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.36
Transcriptomic analysis of human macrophages in 3D 0.36
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 0.34
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.26
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.23
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.22
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.17
RNAseq of Breast cancer PDX samples 0.14
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.12
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 0.11
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.09
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
The cohesin complex prevents Myc-induced replication stress 0.05
ML29755 RNA-seq data 0.05
Human Treg IFNg/IL-10 subpopulations 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation